Alipour1818. Alipour A, Shojaee S, Mohebali M, Tehranidoost M, Abdi Masoleh F, Keshavarz H. Toxoplasma infection in schizophrenia patients: a comparative study with control group. Iran J Parasitol. 2011;6:31-7. |
6 |
Campos-Carli1919. Campos-Carli SM de, Vieira ÉLM, Rocha NP, de Oliveira K, Guimarães FC, Barbosa IG, et al. Toxoplasma gondii infection and chronic schizophrenia: is there any association? Arch Clin Psychiatry. 2017;44:145-8. |
7 |
Alvarado-Esquivel2020. Alvarado-Esquivel C, Urbina-Álvarez JD, Estrada-Martínez S, Torres-Castorena A, Molotla-de-León G, Liesenfeld O, et al. Toxoplasma gondii infection and schizophrenia: a case control study in a low toxoplasma seroprevalence Mexican population. Parasitol Int. 2011;60:151-5. |
7 |
Emelia2121. Emelia O, Amal RN, Ruzanna ZZ, Shahida H, Azzubair Z, Tan KS, et al. Seroprevalence of anti-toxoplasma gondii IgG antibody in patients with schizophrenia. Trop Biomed. 2012;29:151-9. |
6 |
Ansari-Lari2222. Ansari-Lari M, Farashbandi H, Mohammadi F. Association of toxoplasma gondii infection with schizophrenia and its relationship with suicide attempts in these patients. Trop Med Int Health. 2017;22:1322-7. |
9 |
Hamdani2323. Hamdani N, Bengoufa D, Godin O, Doukhan R, Le Guen E, Daban-Huard C, et al. Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent toxoplasma gondii infection. BMC Psychiatry. 2018;18:239. |
8 |
Blomström2424. Blomström Å, Karlsson H, Wicks S, Yang S, Yolken RH, Dalman C. Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring-a matched case-control study. Schizophr Res. 2012;140:25-30. |
9 |
Hinze-Selch1111. Hinze-Selch D, Däubener W, Eggert L, Erdag S, Stoltenberg R, Wilms S. A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr Bull. 2007;33:782-8. |
7 |
Cetinkaya2525. Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodies in patients with schizophrenia - preliminary findings in a Turkish sample. Schizophr Bull. 2007;33:789-91. |
7 |
Horacek2626. Horacek J, Flegr J, Tintera J, Verebova K, Spaniel F, Novak T, et al. Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study. World J Biol Psychiatry. 2012;13:501-9. |
7 |
Chen2727. Chen B, Chen B, Hou X, Zheng C, Yang X, Ke J, et al. Association between toxoplasma gondii infection and psychiatric disorders in Zhejiang, Southeastern China. Acta Trop. 2019;192:82-6. |
8 |
Karabulut2828. Karabulut N, Bilgiç S, Gürok MG, Karaboğa F. Is there any role of latent toxoplasmosis in schizophrenia disease? J Chin Med Assoc. 2015;78:533-7. |
8 |
Dogruman-Al2929. Dogruman-Al F, Aslan S, Yalcin S, Kustimur S, Turk S. A possible relationship between toxoplasma gondii and schizophrenia: a seroprevalence study. Int J Psychiatry Clin Pract. 2009;13:82-7. |
7 |
Khademvatan3030. Khademvatan S, Khajeddin N, Izadi S, Yousefi E. Investigation of anti- toxocara and anti- toxoplasma antibodies in patients with schizophrenia disorder. Schizophr Res Treatment. 2014;2014:230349. |
8 |
Esshili3131. Esshili A, Thabet S, Jemli A, Trifa F, Mechri A, Zaafrane F, et al. Toxoplasma gondii infection in schizophrenia and associated clinical features. Psychiatry Res. 2016;245:327-32. |
8 |
Khademvatan3232. Khademvatan S, Saki J, Khajeddin N, Izadi-Mazidi M, Beladi R, Shafiee B, et al. Toxoplasma gondii exposure and the risk of schizophrenia. Jundishapur J Microbiol. 2014;7:e12776. |
7 |
Hamidinejat3333. Hamidinejat H, Ghorbanpoor M, Hosseini H, Alavi SM, Nabavi L, Jalali MH, et al. Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia. Int J Infect Dis. 2010;14:e978-81. |
6 |
Pearce3434. Pearce BD, Hubbard S, Rivera HN, Wilkins PP, Fisch MC, Hopkins MH, et al. Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controls. Schizophr Res. 2013;150:258-61. |
7 |
Morais3535. Morais FB, Arantes TE, Muccioli C. Seroprevalence and manifestations of ocular toxoplasmosis in patients with schizophrenia. Ocul Immunol Inflamm. 2019;27:134-7. |
6 |
Yolken3636. Yolken R, Torrey EF, Dickerson F. Evidence of increased exposure to toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia. PLoS Negl Trop Dis. 2017;11:e0006040. |
8 |
Mortensen3737. Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Torrey EF, et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry. 2007;61:688-93. |
9 |
- |
- |
Omar3838. Omar A, Bakar OC, Adam NF, Osman H, Osman A, Suleiman AH, et al. Seropositivity and serointensity of toxoplasma gondii antibodies and DNA among patients with schizophrenia. Korean J Parasitol. 2015;53:29-34. |
7 |
- |
- |
Tamer3939. Tamer GS, Dundar D, Yalug I, Caliskan S, Yazar S, Aker A. The schizophrenia and toxoplasma gondii connection: Infectious, immune or both? Adv Ther. 2008;25:703-9. |
6 |
- |
- |
Yuksel4040. Yuksel P, Alpay N, Babur C, Bayar R, Saribas S, Karakose AR, et al. The role of latent toxoplasmosis in the aetiopathogenesis of schizophrenia - the risk factor or an indication of a contact with cat? Folia Parasitol (Praha). 2010;57:121-8. |
7 |
- |
- |
Mean score (± SD) |
7.28 (± 1.13) |
|
7.3 (± 0.67) |